Kinetic assembly tuning NIR-II cyanine aggregated states: Remarkable photothermal-mediated sustained retention in orthotopic hepatoma Authors: Yue Wu, Meiling Zhao, Menglan Wu, Jialiang Huang, Yutao Zhang, Chenxu Yan, Wei-Hong Zhu, Zhiqian Guo, Yisheng Xu Published: 2026 ABSTRACT Conventional photothermal nanotheranostics suffer from fluorescence quenching caused by energy transfer between imaging and photothermal agents. Although unimolecular nanotheranostic systems circumvents the issue, it remains inadequate for generating substantial fluorescence and photothermal effects simultaneously under single-wavelength excitation. Herein, we develop a molecular aggregation engineering strategy by spectrally decoupling the monomeric state for fluorescence from the aggregated state for photothermal conversion within a unimolecular dye nanoplatform, enabling simultaneous theragnostic. We introduce a kinetic assembly method to encapsulate both NIR-II dyes (DQP) and protein in polymers, precisely regulating the aggregated state. Moreover, strong π-π stacking of the aggregated state of DQP drives photothermal effect, which functions as a thermal stimuli trigger for temperature-responsive DQPNPs to achieve charge reduction and size enlargement, promoting intracellular tumor retention, which ultimately improves fluorescence intensity and enhances photothermal efficacy. Such a molecular aggregation engineering strategy ensures precise tuning of the aggregated state of dyes, which realizes a breakthrough for balance NIR-II fluorescence with photothermal effect, supporting personalized and long-term cancer therapy. INTRODUCTION Photothermal therapy (PTT) has gained considerable attention in cancer therapy due to its spatiotemporal controllability, noninvasiveness, and reduced systemic toxicity (1–8). However, conventional PTT nanotheranostics still face inherent challenges: fluorescence signal quenching caused by unavoidable energy transfer between emissive and photothermal constituents (9–15). Therefore, there is an urgent need to develop a new paradigm of nanotheranostic platforms capable of intrinsically avoiding cross-talk while enabling synergistic functional integration. To overcome this limitation, a unimolecular framework for both fluorescence imaging and photothermal effects can be used to circumvent quenching (16–21). However, most individual dyes struggle to efficiently generate substantial fluorescence and photothermal effects simultaneously under the same excitation conditions (22–24). Therefore, separating the excitation wavelengths for diagnostic fluorescence imaging and therapeutic PTT may serve as an effective solution. In light of this, cyanine dyes with the well-defined aggregation-dependent photophysical properties offer a unique opportunity to implement this strategy. Specially, the absorption of cyanine dyes can be tuned from the molecular state to distinct aggregated states (H- or J-aggregates) through specific interactions with macromolecular templates, such as proteins (25–29). Nevertheless, simultaneous and precise coexistence of molecular and aggregated states of dyes within a single nanoparticle remains a substantial synthetic challenge, necessitating the development of a kinetic assembly preparation method to regulate the molecular and aggregation structure with high precision. Herein, we innovatively used amphiphilic polymers to coencapsulate both proteins and NIR-II dyes (DQP) through a kinetically driven assembly method, introducing proteins as predefined aggregation sites to locally induce the formation of DQP aggregates, enabling the integration of molecular and aggregated states within the same nanotheranostics [DQPNPs (+)] (Fig. 1). Furthermore, by using temperature-responsive polymers (PDMAEMA-b-PCL) (30–32), positively charged nanotheranostics were formulated by kinetic assembly to obtain high cell membrane penetration, in which the initial enrichment of DQPNPs (+) at the tumor site was achieved through electrostatic interactions. Subsequently, because of the intense π-π stacking interactions of the cyanine dye, the aggregated state of dye causes the photothermal effect as a temperature-responsive switch, which realized photothermal-induced sustained tumor retention in vivo. Specifically, temperature variations were used to trigger the DQPNPs (+) temperature-responsive behavior leading to an increase in size through particle aggregation and a decrease in charge, allowing nanoaggregates to be retained within the cells, thereby enhancing extracellular uptake efficiency while preventing exclusion and degradation. Moreover, both in vitro and in vivo photothermal effects of DQPNPs (+) were investigated. This uniting molecular and aggregated state strategy offers a novel unimolecular dye nanotheranostic system design, which realizes a breakthrough for drug delivery and monitoring, supporting personalized and long-term cancer therapy. Protein-induced controllable molecular aggregation engineering strategy based on kinetic assembly. (A) Chemical structures and formation of DQPNPs (+) by kinetic assembly, spectrally decoupling the molecular state from the aggregated state within a unimolecular dye nanoplatform. (B) Photothermal-mediated sustained retention in tumor was realized by size increase and charge decrease, with the molecular state for NIR-II fluorescence and the aggregated state for PTT. RESULTS Construction of protein-induced stable nanotheranostics (DQPNPs) DQP cyanine dye was synthesized by a four-step reaction (fig. S1). DQPNPs were prepared by DQP, proteins, and block copolymers (BCPs) via a flash nanoprecipitation (FNP) method. Through the FNP method, parameters could be manipulated to adjust the DQPNPs achieving desired size and surface charge (33–39). The protein acted as nucleation as well as aggregation sites for DQP, which is able to form a complex with a particle size of around 300 nm (fig. S2A). However, it is not stable in the aqueous phase, where precipitates were observed within 24 hours (fig. S2B). Thus, the amphiphilic BCPs were introduced as stabilizers for formulating stable DQPNPs. The particle stability, encapsulation efficiency (EE), and loading capacity of DQPNPs were investigated by tuning the concentrations of proteins, BCPs, and DQP probes (fig. S3). Although the EE of DQP increased and the absorption intensity became stronger as the concentration of protein was increased, the corresponding stability of DQPNPs decreased (figs. S4 to S7). In contrast, with the increase in BCP concentration, the stability of DQPNPs was enhanced, yet the loading capacity was decreased (figs. S8 to S11). Therefore, the concentration of DQP was increased on the basis of which the good particle stability and high EE could be maintained while the loading capacity was increased (figs. S12 to S15). However, to reach temperature-responsive DQPNPs with positive charge, the proportion of temperature-responsive BCPs was also a key parameter, which, in addition to providing temperature-responsive performance, directly affected the charge of DQPNPs. As the concentration of temperature-responsive BCPs increased, the size of DQPNPs became smaller and with a narrower size distribution along with increasing positive charges (figs. S16 and S17). However, the positive charge of DQPNPs could not be too large, which would inversely result in the destabilization of DQPNPs in serum (fig. S18), thus limiting the application in vivo. In addition, the flow rate of the FNP process was varied to examine the influence of turbulent mixing on the molecular and aggregated states of DQPNPs. As shown in fig. S19, increasing the flow rate led to a gradual reduction in particle size and an improvement in size dispersion. This trend was attributable to the enhanced turbulence intensity at higher flow rates, which was quantified by the Reynolds number (Re)Re = ∑i = 1nRei = dA∑i = 1nρiQiμi = 4πd∑i = 1nρiQiμi(1)where ρ is the density of the stream (kg m−3), d is the stream inlet diameter, μ is the viscosity of the stream (kg m−1 s−1), A is the pipe cross-sectional area (m2), and Qi is the volumetric flow rate (m3 s−1) of the ith inlet stream. With increasing flow rate, the corresponding rise in Re reflected stronger turbulent mixing, thereby promoting the dispersion of DQP and favoring its molecular state over the aggregated state within the DQPNPs (fig. S20). Besides, different proteins were assembled with DQP to form DQPNPs. Although Hb failed to yield stable nanoparticles (fig. S21), DQPNPs prepared via FBS were stable (fig. S22) and exhibited absorbance characteristic of both aggregate and molecular states (fig. S23). Collectively, these findings could broaden the applicability of this kinetic assembly strategy. Therefore, after consideration of EE, loading capacity, and stability in serum, DQPNPs (+) as the optimized particles were prepared at the condition: using PEG-DSPE as the stabilizer and PDMAEMA-b-PCL as the temperature-responsive agent with a mass ratio of 10 wt %. As shown in Fig. 2A, under identical conditions, nanotheranostics synthesized via thermodynamic assembly methods (TM) precipitate immediately (figs. S24 and S25), whereas DQPNPs (+) synthesized via kinetic assembly methods (FNP) remain stable (fig. S26). Consequently, the EE for DQPNPs-TM was determined to be as low as 6%. By contrast, the EE for DQPNPs (+) was 61%, representing an ∼10-fold increase. The size of DQPNPs (+) obtained was about 250 nm with a PDI of 0.1 (Fig. 2B), which was a suitable particle size for the EPR effect (40, 41). In addition, the DQPNPs (+) was stable after 30 days in both phosphate-buffered saline (PBS) and serum (fig. S27), due to the low positive zeta potential (fig. S28). In contrast, the temperature-responsive BCP empty micelles and free DQP probe with higher positive zeta potentials were unstable in serum. Similarly, smaller particle sizes and narrower particle size distributions were observed for negatively charged DQPNPs (−) and neutrally charged DQPNPs (0) (fig. S29), which was also stable for 1 month like DQPNPs (+). Photophysical properties of protein-mediated DQPNPs. (A) DQPNPs (+) prepared by the thermodynamic assembly method and kinetic assembly method, respectively. (B) Particle size distribution of DQPNPs (+) formulated after 0 and 30 days. (C) Schematic illustration, (D) absorption spectra, and (E) photothermic heating curve (Inset: Photothermic heating and NIR-II images) of DQPNPs (+) prepared without protein under 808-nm irradiation (0.5 W cm−2) for 5 min. (F) Schematic illustration, (G) absorption spectra, and (H) photothermic heating curve (Inset: Photothermic heating and NIR-II images) of DQPNPs (+) prepared with protein under 808-nm irradiation (0.5 W cm−2) for 5 min. Fs-TA spectra of DQPNPs (+) at (I) 980 nm and (J) 800 nm over time delays ranging from 0 to 1000 ps. Fs-TA plots of DQPNPs (+) at different pump-probe delay times at (K) 980 nm and (L) 800 nm. (M) Possible interaction mechanism between DQP and protein. Details of the π-π stacking interaction between DQP and protein and binding residues. (N) Schematic illustration of the transformation of TICT induced NIR-II to photothermal effect changing of DQP, including the HOMOs and LUMOs. Discovering DQP-protein interaction for controllable molecular and aggregated states Without introduction of protein to nanotheranostics, DQP existed in a molecular state dispersed within DQPNPs (Fig. 2D and fig. S30). As shown in Fig. 2E and fig. S31, the absorption peak at 980 nm excited NIR-II fluorescence. However, because of the absence of a notable absorption peak at 808 nm, no pronounced photothermal effect was induced. In contrast, the absorption peaks of DQPNPs (+) were at 805 and 980 nm, respectively (Fig. 2G). Comparing to the absorption of the free DQP probe, the peak at 980 nm was a dispersed state of DQP whereas the peak at 805 nm was an aggregated state of DQP in DQPNPs (+) (fig. S32). As shown in Fig. 2H, the aggregated state of DQPNPs (+) can be induce a favorable photothermal effect, whereas the molecular state leading to a strong NIR-II fluorescence intensity. To further investigate the in vitro phototherapy performance of DQPNPs (+), photothermal effect of DQPNPs (+) was carried out against different concentrations (fig. S33), which could easily reach up to about 60°C after laser irradiation (808 nm, 0.5 W cm−2) for 5 min, whereas no temperature increase was observed in PBS (fig. S34). After three on/off cycles, it could be observed that the temperature of DQPNPs (+) raised higher after each cycle (fig. S35). This was due to the fact that DQPNPs (+) were temperature-induced aggregated after the temperature rise (fig. S36), which resulted in the larger particle size ultimately leading to a stronger absorption and enhancing the photothermal effect. Notably, the particle size increased with repeated laser irradiation on/off cycles before plateauing as progressive protein denaturation and saturated polymer stabilization collectively governed this behavior. Furthermore, it can be observed that, as the temperature decreased, the particle size of DQPNPs (+) also decreased. This reversible property of DQPNPs (+) is beneficial for biosafety and long-term circulation within the body. In contrast, DQPNPs (−) were not characterized by such temperature-responsive performance; thus, there was no increase in temperature after each cycle. The emission of DQPNPs (+) was 1050 nm at an excitation of 980 nm, and the fluorescence signals of DQPNPs (+) with different LP filters were carried out, which could not gain an emission at an excitation of 808 nm (figs. S37 and S38). In this case, the aggregates of DQP convert energy into effective photothermal effect instead of fluorescence signals, whereas the monodispersed DQP provides efficient fluorescence signals. This can easily divide the DQPNPs (+) into two channels for NIR-II imaging and PTT without competing. Besides, the photostabilization of DQP was enhanced by preparing into DQPNPs (+) (figs. S39 and S40). This was attributed to the fact that the binding between the DQP and the protein was strong, making the DQP less susceptible to breakage due to vibration after energy absorption. Meanwhile, the DQPNPs (−) were also improved in photostabilization compared to free DQP (figs. S41 to S44). The femtosecond transient absorption (fs-TA) spectra revealed distinct excited-state behaviors for DQP under different excitations. At 980 nm, the negative signal from ground-state bleaching and stimulated emission verified the molecular state (Fig. 2, I and J, and fig. S45), where radiative decay produced strong NIR-II fluorescence. At 800 nm, however, the positive excited-state absorption feature indicated the aggregated state (Fig. 2, K and L, and fig. S46), in which nonradiative relaxation channels dominated and photothermal conversion ensued. Furthermore, we validated the generality of this strategy using perylene, a charge-neutral dye, to formulate nanoparticles (figs. S47 and S48). This observation demonstrates that our kinetically controlled protein-assisted method is not limited to ionic DQP but is broadly applicable to charge-neutral dyes as well. Understanding the mechanism of interaction between DQP and protein was critical to guide efficient nanocomplex synthesis and fluorescence enhancement. Docking modeling was performed to investigate the poses and interaction between DQP and protein (Fig. 2M, fig. S49, and table S1), in which the binding site of DQP was identified as the cleft of protein. The substrate remained stably bound to the protein, with an RMSD (root mean square deviation) value not exceeding 8 Å in the 200-ns simulation (fig. S50) and averaging around 5 Å. This indicated that the substrate can bind stably to the protein (movie S1). According to MM-GBSA calculations, the total energy contribution of the substrate was −36.2 ± 2.1 kcal/mol. Van der Waals forces and nonpolar solvation energy accounted for the largest contributions (table S2), indicating that hydrophobic interactions played a major role in the substrate-protein interaction. After decomposing the MM-GBSA interaction energy into each amino acid of the protein (table S3), the amino acids surrounding the substrate all contributed an amount of energy (fig. S51). The enhanced twisted intramolecular charge transfer (TICT) process (42–44) was further supported by time-dependent density functional theory (TDDFT) calculations at the B3LYP/6-31G(d) level (see the Supplementary Materials for computational details). The corresponding the highest occupied molecular orbital (HOMO), the lowest unoccupied molecular orbital (LUMO), and maps of electrostatic potential (ESP) surfaces were plotted in Fig. 2N and figs. S52 and S53. The narrowing of the bandgap between HOMOs and LUMOs enhances PTT efficiency. Both the HOMOs and LUMOs distributed along the whole molecular backbone, which suggested a strong π-π* local excitation emission. According to the docking modeling with the best-established binding pose between DQP and protein, the rotation with a dihedral angle of 90° created an asymmetric π-conjugated backbone that resulted in charge redistribution and further induced the TICT enhancing the PTT effect. Excellent temperature-responsive properties of DQPNPs (+) Because DQPNPs (+) was designed with a temperature response, the particle size became larger from ∼250 to ∼450 nm, which was observed in the transmission electron microscopy (TEM) and scanning electron microscopy (SEM) images (Fig. 3, A and B, and fig. S54). Moreover, as the size became larger, the potential decreased from 11 to 4 mV at an increase in temperature (Fig. 3C). This was due to the fact that, as the temperature increased, the temperature-responsive BCP exceeded its low critical solution temperature (LCST) (fig. S55), where the hydrophilic blocks transformed into hydrophobic blocks. This led to the aggregation of DQPNPs (+), resulting in an increase in the particle size of the DQPNPs (+) along with the macroscopic potential drop. DQPNPs (0) and DQPNPs (−), on the other hand, have little variation in particle size and potential for they were not temperature responsive (figs. S56 to S61). As shown in Fig. 3D and fig. S62, energy-dispersive x-ray spectroscopy (EDX) mapping and high-resolution TEM image of DQPNPs (+) confirmed that the aggregated state of DQP binding with proteins were encapsulated into the nanotheranostics, leading to the photothermal effect triggering the temperature response performance (fig. S63). Temperature-responsive performance of DQPNPs (+). (A) TEM images of DQPNPs (+) at 25° and 60°C, respectively. (B) Zeta potential and (C) particle size of DQPNPs (+) against different temperatures. (D) EDX images of DQPNPs (+). Scale bars, 100 nm. Data are presented as means ± SD. In vitro photothermal-mediated living cell sustained retention To further investigate the PTT efficiency, the DQPNPs (+) were incubated with living cells with 808-nm irradiation (Fig. 4A). As shown in Fig. 4 (B to D), the fluorescein isothiocyanate (FITC) fluorescence intensity of DQPNPs (+) was stronger than DQPNPs (−) after 12 hours of incubation, resulting in the fact that DQPNPs (+) with the positive surface charge was more efficient for cell internalization than DQPNPs (−) with the negative charge. As shown in Fig. 4E, TEM images demonstrated that the DQPNPs (+) were successfully internalized into MCF-7 cells, whereas the particle size of DQPNPs (+) were enlarged after 808-nm laser irradiation (0.8 W cm−2). Then, in vitro cytotoxicity of DQPNPs (+) were explored by standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. As shown in Fig. 4F and figs. S64 to S66, MCF-7 cells and human umbilical cord endothelial cells (HUVECs) exhibited cell viability with a value of above 90% even at a concentration of 50 μM. This demonstrated that both DQPNPs (+) and DQPNPs (−) did not have direct toxicity to the cells. When the cells incubated with DQPNPs (+) were exposed under 808-nm irradiation, the MTT results clearly showed that there was significant cell toxicity for DQPNPs (+) groups, demonstrating the strong PTT efficiency of DQPNPs (+). Meanwhile, most of the MCF-7 cells were observed to be apoptotic by calcein-AM and propidium iodide (PI) staining (Fig. 4G and fig. S67) and analysis of annexin V–FITC/PI in MCF-7 (fig. S68), also clarified the enhanced photothermal effect in vitro. Furthermore, tumor tissue of MCF-7 cells was treated twice with DQPNPs (+) and DQPNPs (−) (Fig. 4H), showing a more improved PTT efficiency of DQPNPs (+). Therefore, DQPNPs (+) with good stability and photophysical properties showed good photothermal performance and temperature responsiveness, providing a good basis for subsequent in vivo PTT. In vitro imaging and phototherapy performance of DQPNPs (+). (A) Schematic illustration of sequentially tumor targeting through electrostatic interaction and temperature-induced retention of DQPNPs (+). (B) CLSM images and (C and D) corresponding fluorescence intensity FITC fluorescence for MCF-7 cells treated with DQPNPs (+), DQPNPs (0), and DQPNPs (−). Between stage 1 and stage 2, 808-nm irradiation (0.8 W cm−2) was used to trigger the temperature response of DQPNPs (+). Scale bars, 50 μm. a.u., arbitrary units. (E) TEM images of MCF-7 cells incubated with DQPNPs (+) pre– and post–808-nm laser irradiation. (F) MCF-7 cells viability after treatment with different concentrations of DQPNPs (+) with and without 808-nm irradiation (0.8 W cm−2). (G) CLSM images of calcein-AM (green) and PI (red) costained MCF-7 cells upon DQPNPs (+) and treatments with and without 808-nm irradiation (0.8 W cm−2). Scale bar, 50 μm. (H) Images of MCF-7 tumor tissue with twice DQPNPs (+) and DQPNPs (−) treatments. Scale bar, 200 μm. Data are presented as means ± SD. P values are calculated by using a one-way ANOVA with Tukey test. ***P < 0.001. In vivo long-lasting NIR-II monitoring in living mice Given the superior resolution of NIR-II fluorescence, further in vivo NIR-II imaging of mice vasculature was performed with DQPNPs (+). After tail vein injection, whole-body blood vessel fluorescence images were obtained (fig. S69), which showed that both DQPNPs (+) and DQPNPs (−) had a superior NIR-II fluorescence performance. The width of the hindlimb vessels was determined and calculated by Gaussian fitting FWHM (full width at half maximum) of cross-sectional fluorescence intensity curves. Higher spatial resolution was achieved in vascular imaging beyond the 1100-nm window, indicating the outstanding NIR-II bioimaging performance of DQPNPs (figs. S70 and S71). The NIR-II fluorescence imaging of tumors was investigated after administration due to the appropriate particle size and temperature-induced targeting capabilities of DQPNPs (+). As described in Fig. 5A, an MCF-7 cancer tumor model was first established, followed by tail vein injection of DQPNPs (+) for diagnosis and therapy. All the tumor-bearing mice were randomly divided into four groups (n = 3): PBS, DQPNPs (+), DQPNPs (+) with 808-nm laser irradiation, and DQPNPs (−) with 808-nm laser irradiation. As shown in Fig. 5B, the tumor temperature of the DQPNPs (+) group rose rapidly after 808-nm laser irradiation, from 31°C to a maximum temperature of 58°C within 10 min, which was sufficient to cause tumor cell necrosis (>48°C lasting at least 2 min). In contrast, the DQPNPs (−) group and PBS group only reached 54° and 32°C under the same conditions (fig. S72). Furthermore, NIR-II fluorescence imaging of DQPNPs (+) front and side views were explored (Fig. 5, C and D, and fig. S73), where the fluorescence intensity of the tumor site became stronger over time whereas the fluorescence intensity in the intestine site diminished over time. This suggested that DQPNPs (+) were intestinally metabolized and the excretion had a certain fluorescence intensity, whereas no obvious fluorescence signals were detected in the PBS group (fig. S74). In Fig. 5 (E and F) and fig. S75, the brightness of the tumor fluorescence imaging gradually increased over time because of the accumulation of DQPNPs (+) caused by the EPR effect and electrostatic interaction, reaching a maximum at 12 hours after administration with DQPNPs (+). However, DQPNPs (−) required 36 hours to reach a maximum fluorescence, which was attributed to the lower efficiency of the negatively charged DQPNPs (−) in cell membrane penetration. In addition, because DQPNPs (+) were temperature responsive, the particle size could be enlarged upon temperature increase, thus remaining in the tumor for longer periods of time, resulting in prolonged fluorescence durations. To further examine the biodistribution, tumors and major organs were harvested and analyzed by NIR-II fluorescence imaging after DQPNPs (+) administration for 48 hours. The relatively strong fluorescence of the tumor indicated a higher enrichment of DQPNPs (+) in the tumor tissue (figs. S76 to S78). In vivo NIR-II imaging and phototherapy performance of DQPNPs (+) on MCF-7 tumor-bearing mice. (A) Schematic illustration of the experimental design in MCF-7 tumor-bearing nude mice for photothermal performance in vivo. (B) Infrared thermal images and corresponding temperatures of MCF-7 tumor-bearing mice irradiated with a 808-nm laser (0.8 W cm−2) of different times after postinjection of DQPNPs (+) and DQPNPs (−). (C) In vivo NIR-II images and (D) corresponding fluorescence intensity of MCF-7 tumor-bearing mouse under 980-nm laser irradiation after injection of DQPNPs (+) intravenously at time points of 1, 2, 5, 9, 12, 18, 24, 36, and 48 hours. (E) In vivo NIR-II images and (F) corresponding fluorescence intensity of MCF-7 tumor-bearing mice irradiated with a 980-nm laser of different times after postinjection of DQPNPs (+) and DQPNPs (−). (G) Schematic illustration of experimental design in MCF-7 tumor-bearing nude mice for sustained PTT. (H) Tumor size of different treatment groups during the therapy period for 14 days (n = 3). (I) Tumor images at the 14th day of treating by DQPNPs (+), DQPNPs (−), and PBS, respectively. Data are presented as means ± SD. P values are calculated by using a one-way ANOVA with Tukey test. *P < 0.05; **P < 0.01; ***P < 0.001. Owing to the good photothermal properties and temperature-induced tumor targeting, the NIR-II fluorescence imaging–guided in vivo tumor PTT efficacy of DQPNPs (+) was further evaluated. MCF-7 tumor-bearing nude mice were randomly divided into five groups and injected with PBS, DQPNPs (+), DQPNPs (+) with 808-nm laser irradiation, DQPNPs (−) with 808-nm laser irradiation, and DQPNPs-TM with 808-nm laser irradiation, respectively (Fig. 5G). Tumors of mice were stained for hematoxylin and eosin (H&E) 48 hours after PTT (fig. S79). The results confirmed that the cells of the DQPNPs (+) with laser irradiation group [DQPNPs (+)-irr] were significantly necrotic, whereas the control group maintained normal morphology. After the PTT treatment, the tumor volumes and body weights of mice were measured and recorded every 2 days to assess the anticancer effect for 14 days. It was clear that the tumors of the DQPNPs (+)-irr gradually shrank, whereas the tumor growth of the control group did not suffer from inhibition (Fig. 5, H and I). Notably, DQPNPs (−) also achieved substantial antitumor activity, confirming that photothermal conversion is the principal effector in both groups. The superior performance of DQPNPs (+) is attributable to the cooperative interplay of charge-enhanced uptake and temperature-triggered size increase: The former promotes intracellular accumulation, whereas the latter suppresses exocytosis, together leading to prolonged retention without either factor being solely responsible. It is worth noting that the body weight of the mice did not show significant fluctuations during the whole treatment period (fig. S80). The results of these experiments clearly indicate that DQPNPs (+) has prominent PTT efficacy. To further investigate the biosafety of DQPNPs (+), the major organs were evaluated by H&E staining analysis, in which no obvious tissue damage was detected in the major organs of mice including the heart, liver, spleen, lung, and kidney (fig. S81). Enhancing orthotopic hepatoma retention with photothermal-triggered DQPNPs (+) To investigate tumor targeting and therapeutic efficacy in mice orthotopic hepatocellular carcinoma, in situ tumor implantation was performed in the liver region of mice (Fig. 6A). The in situ tumor in the liver was successfully constructed as demonstrated by histological section analysis (fig. S82). Then, the imaging and retention of ex vivo liver in situ tumors were investigated, in which the tumor-bearing liver was removed from the euthanized mice and immersed in DQPNPs. As shown in Fig. 6B and fig. S83, at the first stage, the positively charged DQPNPs (+) accumulated more rapidly at the tumor site. After 5 min of laser irradiation, the liver tissue was immersed in PBS to investigate retention patterns. As immersion time increased, DQPNPs (+) with temperature-responsive particle size expansion exhibited enhanced fluorescence and longer intertumoral retention times (Fig. 6C and fig. S84). Comparing fluorescence intensity between tumor sites and nontumorous liver tissue revealed that DQPNPs (+) demonstrated superior tumor targeting efficacy compared to DQPNPs (−) (Fig. 6D). The tumor fluorescence intensity of negatively charged DQPNPs (−) was even lower than that of the unaffected liver tissue. In situ NIR-II imaging and phototherapy performance of DQPNPs (+) on orthotopic hepatoma mice. (A) Schematic illustration of orthotopic hepatoma for in situ Hepa 1-6 tumor-bearing nude mice. (B) In vivo NIR-II images and (C) corresponding fluorescence intensity of orthotopic hepatoma mice irradiated with a 980-nm laser of different times after postinjection of DQPNPs (+) and DQPNPs (−). (D) Fluorescence intensity ratios of tumor site to liver of DQPNPs (−) and DQPNPs (+) treated mice. (E) In vivo NIR-II images and (F) corresponding fluorescence intensity of orthotopic hepatoma mice irradiated with a 980-nm laser of different times after postinjection of DQPNPs (+). (G) Liver and tumor sites images at the 21th day of treating by DQPNPs (+) and PBS, respectively. Data are presented as means ± SD. P values are calculated by using a one-way ANOVA with Tukey test. **P < 0.01; ***P < 0.001. Subsequently, its tumor retention and therapeutic efficacy were investigated in an in situ liver cancer mouse model. Following intravenous tail injection of DQPNPs (+), prolonged retention of DQPNPs (+) within the liver was observed after laser irradiation (Fig. 6E and fig. S85). Over time, fluorescence intensity decreased in unaffected liver regions while remaining stable in cancerous areas (Fig. 6F). Following PTT treatment, mouse body weights were measured and recorded every 2 days for 21 days to evaluate anticancer efficacy. Results showed that tumors in the DQPNPs (+)-irr group progressively shrank, whereas tumor growth in the control group remained uninhibited (Fig. 6G). Notably, no significant fluctuations in mouse body weight were observed throughout the treatment period (fig. S86). These experimental findings clearly demonstrate the efficient PTT efficacy of DQPNPs (+). To further evaluate the biological safety of DQPNPs (+), major organs were analyzed via H&E staining. Results revealed no significant tissue damage in key organs including the heart, liver, spleen, lungs, and kidneys (fig. S87). DISCUSSION In summary, a novel molecular aggregation engineering strategy was developed by spectrally tuning the monomeric state to the aggregated state, enabling simultaneous theragnostic without energy competition. Unimolecular dye nanotheranostics DQPNPs (+) with high-efficacy fluorescence and PTT was successfully constructed by the kinetic self-assembly of DQP and amphiphilic temperature-responsive polymers by turbulent mixing for sequential targeting with significantly enhanced in vivo NIR-II fluorescence imaging and PTT. DQPNPs (+) showed extremely high stability, high tissue penetration, and remarkable temperature-induced tumor targeting performance. The NIR-II fluorescence signal of DQPNPs (+) was rapidly enriched at the tumor site, which showed a 13.4-fold improvement in fluorescence signals at the tumor site and a 6.7-fold improvement in tumor suppression rate to DQPNPs (−) groups, supporting personalized and long-term cancer therapy. In addition, the PTT efficiency of DQPNPs (+) was also improved. Therefore, this temperature-induced sequential tumor targeting nanotheranostics not only facilitates real-time monitoring of treatment efficacy but also lays the groundwork for long-term, personalized therapies tailored to disease progression. MATERIALS AND METHODS Materials The amphiphilic block copolymer PEG2k-DSPE was purchased from Yarebio. Tetrahydrofuran (THF), ethyl acetate, and acetonitrile were obtained from Shanghai Tansole Chemical Co. Ltd. MTT was purchased from Keygentec (Nanjing, China). Dulbecco’s modified Eagle’s medium (DMEM) and PBS were purchased from Hyclone. Fetal bovine serum (FBS) and penicillin-streptomycin liquid were purchased from Gibco. All the reagents, which were not especially pointed out, were analytical grade, and ultrapure water was used in all experiments. Ultrapure water was obtained by a Milli-Q water purification system. Synthesis of DQPNPs with different potentials The DQPNPs were prepared by FNP through a CIJ-D mixer. DQP at a certain concentration in THF was added to a solution of BCP (PEG2k-DSPE) in THF, where the concentration of DQP ranged from 0.25 to 2 mM and the concentration of BCP ranged from 0.5 to 5.0 mg ml−1. The other stream contained bovine serum albumin (BSA) and water at a certain ratio, which was determined by the weight ratio of FBS to BCP ranging from 1:10 to 5:1. The two streams were fed at the flow rate of 50 ml min−1 using digitally controlled syringe pumps (Harvard Apparatus, PHD 2000) to yield DQPNP suspensions. The resulting DQPNP suspensions were dialyzed in water for 24 hours and lastly dispersed in pure water. The DQPNPs (−) (DQPNPs with negative potential), DQPNPs (0) (DQPNPs with less positive potential), and DQPNPs (+) (DQPNPs with positive potential) were prepared through the same process. DQP (1 mg ml−1) in THF was added to a solution of BCP (PEG2k-DSPE and PDMAEMA-b-PCL) in THF, where the weight ratio of PEG2k-DSPE and PDMAEMA-b-PCL ranged from 0:1 to 1:0. The other stream contained BSA (4 mg ml−1) in water. The two streams were fed at the flow rate of 50 ml min−1 using digitally controlled syringe pumps. The resulting DQPNP suspensions were dialyzed in water for 24 hours and lastly dispersed in pure water. In vitro photothermal effect The photothermal properties of PBS, DQPNPs (−), DQPNPs (+), and DQPNPs-TM were investigated with a handheld thermographic camera (HIKVISION DS-2TPH10-3AUF, China). First, 200 μl of the solutions was added into a tube and treated with an 808-nm NIR laser for 5 min. During laser irradiation, the thermographic camera would record the temperature changes in the solution and provide real-time thermal imaging. Last, the photothermal heating curve of the sample solution was obtained at different time intervals. Cell culture MCF-7 cells, Hepa 1-6 cells, and HUVECs were provided by the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS). Hepa 1-6 cells, MCF-7 cells, and HUVECs were grown in DMEM supplemented with 10% FBS and 1% antibiotic/antimycotic solution (penicillin and streptomycin; Invitrogen). All cells were cultured at 37°C under 5% CO2. Confocal fluorescence imaging of DQPNPs The FITC-loaded DQPNPs were used to determine the uptake of NPs by the living cells. Briefly, MCF-7 cells were seeded at a density of 1 × 105 cells in 1 ml per well in a confocal laser scanning microscopy (CLSM) cell culture dish and incubated for 24 hours at 37°C under 5% CO2. Then, the obtained DQPNPs (−), DQPNPs (0), and DQPNPs (+) were added to the culture dish, respectively. After incubation for 6 hours, the cells were washed three times with PBS, followed by using 4% paraformaldehyde solution to fix cancer cells. Last, the fluorescence imaging was performed with a Leica TCS SP8 with the laser excitation wavelength of 488 nm. All the treatments were performed three times. Cytotoxicity of DQPNPs In vitro cytotoxicity was measured by using MTT assay. Dark cytotoxicity of DQPNPs (−), DQPNPs (+), and DQPNPs-TM MCF-7 cells, same as HUVECs, were cultivated in 96-well plates at a density of 1 × 104/100 μl containing DMEM at 37°C and 5% CO2 for 12 hours. Subsequently, the medium was next replaced by fresh medium containing different concentrations of optimized DQPNPs (−) and DQPNPs (+) (0, 1, 5, 10, 25, and 50 μM), respectively. After incubation for another 12 hours, MTT (50 μl) was added to each well and the plate was incubated for an additional 4 hours at 37°C under 5% CO2. Then, adding 150 μl of DMSO, the assay plate was allowed to stand at room temperature for 20 min. A Tecan Infinite M200 monochromator-based multifunction microplate reader was used to measure the optical density (OD) at 570 nm (Abs) of each well with background subtraction at 490 nm. The following formula was used to calculate the cell viabilityCell viability (%)=mean Abs value of treatment groupmean Abs value of control group × 100%(2) Cytotoxicity of photothermal effect caused by DQPNPs MCF-7 cells were cultivated in 96-well plates at a density of 1 × 104/100 μl containing DMEM at 37°C and 5% CO2 for 12 hours. The cells were incubated with DQPNPs (−) and DQPNPs (+) (0, 1, 5, 10, 25, and 50 μM) for 30 min, respectively, and then exposed to 808-nm laser irradiation (0.8 W cm−2, 5 min). Then, the relative cell viability was measured by MTT assay as the “Dark cytotoxicity of DQPNPs (−), DQPNPs (+), and DQPNPs-TM” section. TEM imaging of living cells MCF-7 cells were incubated with DQPNPs (+) for 30 min and then exposed to 808-nm laser irradiation (0.8 W cm−2, 5 min). After incubation for another 12 hours, MCF-7 cells were collected at an amount of 1 × 107 and immediately fixed in a centrifuge tube containing 2.5% glutaraldehyde for 24 hours. Then, the samples of MCF-7 cells were treated as follows: dehydrate, resin penetration, embedding, and polymerization into resin blocks. The resin blocks were trimmed to 70 to 90 nm in thickness using an ultramicrotome (Leica UC7). Last, the samples were examined for charge-coupled device imaging in TEM (HITACHI HT7800) in the voltage of 80 kV. Animal experiments and histological staining All animal experiments were conducted under guidelines in accordance with The National Regulation of China for Care and Use of Laboratory Animals (animal ethics application approval number iECUST-2021-07001). The nude mice were purchased from Nanjing Junke Bioengineering Co. Ltd. To establish MCF-7 tumors in BALB/c nude mice (average weight: 20 g), 2 × 106 MCF-7 cells in 100 μl of PBS suspension were subcutaneously injected into the right armpit of the mice. Treatments were initiated when tumors reached a mean group size of ∼80 to 100 mm3. The tumor volumes were calculated as followsvolume=(tumor length) × (tumor width)2 × 0.5(3) The mice were randomly divided into six groups (n = 3): PBS group, PBS with laser group, DQPNPs (−) group, DQPNPs (−) with laser group, DQPNPs (+) group, and DQPNPs (+) with laser group. The 808-nm laser was used to irradiate the tumor for 5 min every 2 days after proinjection of samples. The tumor sizes and body weights were monitored every 2 days. The relative tumor volumes were calculated as follows: V/V0 (V0 is the original tumor size, and V represents the tumor volume recorded during the phototherapy). After treatments, the tested mice were euthanized to collect the tumors and main organs (liver, lung, heart, kidney, intestine, and spleen) from different groups for further histology analysis. To obtain orthotopic hepatoma for Hepa 1-6 tumor-bearing nude mice (average weight: 20 g), 2 × 106 Hepa 1-6 cells in 100 μl of PBS suspension was in situ injected into the liver of the mice. The mice were randomly divided into three groups (n = 3): PBS with laser group, DQPNPs (+) group, and DQPNPs (+) with laser group. The tumor sizes and body weights were monitored every 2 days. After treatments, the tested mice were euthanized to collect the main organs (liver, lung, heart, kidney, intestine, and spleen) from different groups for further histology analysis. In vivo NIR-II fluorescence imaging and photothermal imaging MCF-7 tumor-bearing mice were injected with DQPNPs (0.5 mg kg−1), in vivo NIR-II fluorescence images were recorded at different time points by the Lumina LT Series III in vivo imaging system. In vivo photothermal images were collected using a handheld thermographic camera with laser irradiation of 808 nm (0.25 W cm−2). Statistical analysis The experimental data were analyzed using means ± SD with at least three experiments (n ≥ 3). Analysis of variance (ANOVA) was used to assess statistical significance: *P < 0.05, **P < 0.01, and ***P < 0.001. The Origin 2018 software was used for statistical analysis. More detailed methods can be found in the Supplementary Materials.